Poly(lactide-co-trimethylene carbonate)s


Poly(lactide-co-trimethylene carbonate)s (PTMCLA) copolymers were synthesized by ring-opening polymerization using l-lactide (LLA) and trimethylene carbonate (TMC) as raw materials. The properties of the copolymer depend on the TMC content. In vitro degradation of copolymers was performed in pH7.4 phosphate buffered saline at 37°C. The higher the TMC content, the stronger the degradation ability of the copolymer. In addition, studies have shown that PTMCLA copolymers have extremely low cytotoxicity and good blood compatibility. Therefore, these materials are more suitable for use in biomedical fields, such as bioabsorbable sutures, implantable medical devices, tissue engineering scaffolds, and controlled release drug systems.

CD Bioparticles offers PTMCLA for solid phase drug delivery and implantable systems. In addition, we also offer PTMCLA modified with ester and hydroxyl groups. Contact us to learn how PTMCLA can help your work.

PTMCLA

Catalog: CDPB036

Viscosity: I.V. 1.0-2.0 dL/g, 0.1% in chloroform at 25°C

TMC:DL 50:50

PTMCLA

Catalog: CDPB037

Viscosity: I.V. 0.5-1.0 dL/g, 0.1% in chloroform at 25°C

TMC:DL 50:50

PTMCLA

Catalog: CDPB016

Viscosity: I.V. 0.5-1.0 dL/g, 0.1% in chloroform at 25°C

LA:TMC 60/40

PTMCLA

Catalog: CDPB033

Viscosity: I.V. 1.0-2.0 dL/g, 0.1% in chloroform at 25°C

TMC:LA 60:40

PTMCLA

Catalog: CDPB034

Viscosity: I.V. 1.0-2.0 dL/g, 0.1% in chloroform at 25°C

TMC:LA 80:20

PTMCLA

Catalog: CDPB035

Viscosity: I.V. 1.0-2.0 dL/g, 0.1% in chloroform at 25°C

TMC:LA 90:10

Products

Fill out the form below
to receive a quote

GET A QUOTE

Contact Us

  • Tel: (USA)
  • Tel: (Europe)
  • Fax:
  • Email:

Newsletter

Copyright © 2022 CD Bioparticles. All rights reserved.
0
Inquiry Basket